|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM238064018 |
| 003 |
DE-627 |
| 005 |
20250217002919.0 |
| 007 |
tu |
| 008 |
231224s2013 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed25n0793.xml
|
| 035 |
|
|
|a (DE-627)NLM238064018
|
| 035 |
|
|
|a (NLM)24808630
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Rosas, Scott R
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Modeling the dissemination and uptake of clinical trials results
|
| 264 |
|
1 |
|c 2013
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 21.10.2021
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 520 |
|
|
|a A select set of highly cited publications from the National Institutes of Health (NIH) HIV/AIDS Clinical Trials Networks was used to illustrate the integration of time interval and citation data, modeling the progression, dissemination, and uptake of primary research findings. Following a process marker approach, the pace of initial utilization of this research was measured as the time from trial conceptualization, development and implementation, through results dissemination and uptake. Compared to earlier studies of clinical research, findings suggest that select HIV/AIDS trial results are disseminated and utilized relatively rapidly. Time-based modeling of publication results as they meet specific citation milestones enabled the observation of points at which study results were present in the literature summarizing the evidence in the field. Evaluating the pace of clinical research, results dissemination, and knowledge uptake in synthesized literature can help establish realistic expectations for the time course of clinical trials research and their relative impact toward influencing clinical practice
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a citation milestones
|
| 650 |
|
4 |
|a dissemination
|
| 650 |
|
4 |
|a scientific output
|
| 650 |
|
4 |
|a uptake
|
| 700 |
1 |
|
|a Schouten, Jeffrey T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Cope, Marie T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kagan, Jonathan M
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Research Evaluation
|d 1998
|g 22(2013), 3 vom: 02. Sept., Seite 179-186
|w (DE-627)NLM098199595
|x 0958-2029
|7 nnns
|
| 773 |
1 |
8 |
|g volume:22
|g year:2013
|g number:3
|g day:02
|g month:09
|g pages:179-186
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 22
|j 2013
|e 3
|b 02
|c 09
|h 179-186
|